Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions

ABSTRACT

Patients with cystic fibrosis (CF) exhibit significant variability in the course and severity of the disease, and this variability is best interpreted in the context of an interaction between genetic and nongenetic determinants. While a small number of patients with “mild” mutations in the CF transmembrane conductance regulator gene clearly have less severe disease, for the general population of patients with CF the strongest predictor of severity of clinical course appears to be socioeconomic status (SES). Low SES probably exerts an influence via the convergence of detrimental environmental influences on outcome such as environmental tobacco smoke, poor nutrition, and stress. Other important predictors that appear to be independent of SES include gender and acquisition of airway pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex. Finally, effective provision of medical interventions is an important determinant of outcome, and this is affected primarily by patient adherence (which bears a poorly defined relationship to SES), and attendance at a CF care center that utilizes a system of care that allows optimal delivery of evidence-based interventions.

KEYWORDS

Cystic fibrosis - outcome assessment (health care) - socioeconomic factors - nutritional status - psychological stress - tobacco smoke pollution - treatment refusal - quality of health care

REFERENCES

• 1 FitzSimmons S C. The changing epidemiology of cystic fibrosis.  J Pediatr . 1993;  122 1-9
• 2 Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2001 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation 2002
• 3 Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.  Hum Genet . 1994;  93 364-368
• 4 Kulczycki L L, Kostuch M, Bellanti J A. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations.  Am J Med Genet . 2003;  116A 262-267
• 5 Lester L A, Kraut J, Lloyd-Still J. et al . Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population.  Pediatrics . 1994;  93 114-118
• 6 Kerem E, Corey M, Kerem B S. et al . The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508).  N Engl J Med . 1990;  323 1517-1522
• 7 Hubert D, Bienvenu T, Desmazes-Dufeu N. et al . Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.  Eur Respir J . 1996;  9 2207-2214
• 8 Loubieres Y, Grenet D, Simon-Bouy B. et al . Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.  Chest . 2002;  121 73-80
• 9 Rozmahel R, Wilschanski M, Matin A. et al . Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.  Nat Genet . 1996;  12 280-287
• 10 Zielenski J. Genotype and phenotype in cystic fibrosis.  Respiration . 2000;  67 117-133
• 11 Drumm M L. Modifier genes and variation in cystic fibrosis.  Respir Res . 2001;  2 125-128
• 12 Acton J D, Wilmott R W. Phenotype of CF and the effects of possible modifier genes.  Paediatr Respir Rev . 2001;  2 332-339
• 13 Mahadeva R, Lomas D A. Secondary genetic factors in cystic fibrosis lung disease.  Thorax . 2000;  55 446
• 14 Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.  Am J Med Genet . 2002;  111 88-95
• 15 Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989.  Am J Epidemiol . 1996;  143 1007-1017
• 16 Demko C A, Byard P J, Davis P B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.  J Clin Epidemiol . 1995;  48 1041-1049
• 17 Hudson I, Phelan P D. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis?.  Pediatr Pulmonol . 1987;  3 288-297
• 18 O'Connor G T, Quinton H B, Kahn R. et al . Case-mix adjustment for evaluation of mortality in cystic fibrosis.  Pediatr Pulmonol . 2002;  33 99-105
• 19 Rosenfeld M, Davis R, FitzSimmons R, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality.  Am J Epidemiol . 1997;  145 794-803
• 20 Guilbault C, Stotland P, Lachance C. et al . Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.  Immunology . 2002;  107 297-305
• 21 Allen J R, McCauley J C, Selby A M. et al . Differences in resting energy expenditure between male and female children with cystic fibrosis.  J Pediatr . 2003;  142 15-19
• 22 Stallings V A. Gender, death and cystic fibrosis: is energy expenditure a component?.  J Pediatr . 2003;  142 4-6
• 23 Jolly D L, Nolan T, Moller J, Vimpani G. The impact of poverty and disadvantage on child health.  J Paediatr Child Health . 1991;  27 203-217
• 24 Mackenbach J P, Kunst A E, Cavelaars A E, Groenhof F, Geurts J J. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health.  Lancet . 1997;  349 1655-1659
• 25 Dimissie K, Ernst P, Hanley J A, Locher U, Menzies D, Becklake M. Socioeconomic status and lung function among primary school children in Canada.  Am J Respir Crit Care Med . 1996;  153 719-723
• 26 Ernst P, Demissie K, Joseph L, Locher U, Becklake M R. Socioeconomic status and indicators of asthma in children.  Am J Respir Crit Care Med . 1995;  152 570-575
• 27 Halfon N, Newacheck P W. Childhood asthma and poverty; differential impacts and utilization of health services.  Pediatrics . 1993;  91 56-61
• 28 Finkelstein J A, Brown R W, Schneider L C. et al . Quality of care for preschool children with asthma: the role of social factors and practice setting.  Pediatrics . 1995;  95 389-394
• 29 Weiss K B. Inner-city asthma: the epidemiology of an emerging US public health concern.  Chest . 1992;  101 S362-S367
• 30 Britton J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis.  BMJ . 1989;  298 483-487
• 31 Macpherson C, Redmond A O, Leavy A, McMullan M. A review of cystic fibrosis children born to single mothers.  Acta Paediatr . 1998;  87 397-400
• 32 Westwood A T. The prognosis of cystic fibrosis in the Western Cape region of South Africa.  J Paediatr Child Health . 1996;  32 323-326
• 33 Schechter M S, Margolis P A. Relationship between socioeconomic status and disease severity in cystic fibrosis.  J Pediatr . 1998;  132 260-264
• 34 Schechter M S, Shelton B J, Margolis P A, FitzSimmons S C. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.  Am J Respir Crit Care Med . 2001;  163 1331-1337
• 35 O'Connor G T, Quinton H B, Kneeland T. et al . Median household income and mortality rate in cystic fibrosis.  Pediatrics . 2003;  111 e333-e339
• 36 Wilkinson R G. Income inequality, social cohesion, and health: clarifying the theory-a reply to Muntaner and Lynch.  Int J Health Serv . 1999;  29 525-543
• 37 Krieger N, Williams D R, Moss N E. Measuring social class in US public health research: concepts, methodologies, and guidelines.  Annu Rev Public Health . 1997;  18 341-378
• 38 Kennedy B P, Kawachi I, Glass R, Prothrow-Stith D. Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis.  BMJ . 1998;  317 917-921
• 39 Kawachi I, Kennedy B P. Income inequality and health: pathways and mechanisms.  Health Serv Res . 1999;  34 215-227
• 40 Reijneveld S A. The impact of individual and area characteristics on urban socioeconomic differences in health and smoking.  Int J Epidemiol . 1998;  27 33-40
• 41 Smith G D, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study.  BMJ . 1998;  316 1631-1635
• 42 Gazmararian J A, Adams M M, Pamuk E R. Associations between measures of socioeconomic status and maternal health behavior.  Am J Prev Med . 1996;  12 108-115
• 43 Davey Smith G, Hart C, Hole D. et al . Education and occupational social class: which is the more important indicator of mortality risk?.  J Epidemiol Community Health . 1998;  52 153-160
• 44 Liberatos P, Link B G, Kelsey J L. The measurement of social class in epidemiology.  Epidemiol Rev . 1988;  10 87-120
• 45 Johnson N J, Sorlie P D, Backlund E. The impact of specific occupation on mortality in the US National Longitudinal Mortality Study.  Demography . 1999;  36 355-367
• 46 Fein O. The influence of social class on health status: American and British research on health inequalities.  J Gen Intern Med . 1995;  10 577-586
• 47 Zill N. Parental schooling and children's health.  Public Health Rep . 1996;  111 34-43
• 48 Rothman K J, Greenland S. Modern Epidemiology.  2nd ed. Philadelphia: Lippincott-Raven; 1998
• 49 Holahan J, Rowland D, Feder J, Heslam D. Explaining the recent growth in Medicaid spending.  Health Aff . 1993;  12 177-193
• 50 Pincus T, Esther R, DeWalt D A, Callahan L F. Social conditions and self-management are more powerful determinants of health than access to care.  Ann Intern Med . 1998;  129 406-411
• 51 Schmitzberger R, Rhomberg K, Buchele H. et al . Effects of air pollution on the respiratory tract of children.  Pediatr Pulmonol . 1993;  15 68-74
• 52 Apter A J, Reisine S T, Affleck G, Barrows E, ZuWallack R L. Adherence with twice-daily dosing of inhaled steroids: socioeconomic and health-belief differences.  Am J Respir Crit Care Med . 1998;  157 1810-1817
• 53 Schenker M B, Samet J M, Speizer F E. Risk factors for childhood respiratory disease: the effect of host factors and home environmental exposures.  Am Rev Respir Dis . 1983;  128 1038-1043
• 54 Stoddard J J, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illness in children.  Am J Epidemiol . 1995;  141 96-102
• 55 Tager I B, Ngo L, Hanrahan J P. Maternal smoking during pregnancy.  Am J Respir Crit Care Med . 1995;  152 977-983
• 56 Rubin B K. Exposure of children with cystic fibrosis to environmental tobacco smoke.  N Engl J Med . 1990;  323 782-788
• 57 Smyth A, O'Hea U, Williams G, Smyth R, Heaf D. Passive smoking and impaired lung function in cystic fibrosis.  Arch Dis Child . 1994;  71 353-354
• 58 Kovesi T, Corey M, Levison H. Passive smoking and lung function in cystic fibrosis.  Am Rev Respir Dis . 1993;  148 1266-1271
• 59 Campbell III W P, Parker R A, Roberts B T, Krishnamani M R, Phillips III A J. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion.  J Pediatr . 1992;  120 261-264
• 60 Gilljam H, Stenlund C, Ericsson-Hollsing A, Strandvik B. Passive smoking in cystic fibrosis.  Respir Med . 1990;  84 289-291
• 61 Schuster M A, Franke T, Pham C B. Smoking patterns of household members and visitors in homes with children in the United States.  Arch Pediatr Adolesc Med . 2002;  156 1094-1100
• 62 Butz A M, Rosenstein B J. Passive smoking among children with chronic respiratory disease.  J Asthma . 1992;  29 265-272
• 63 Nelson D E, Emont S L, Brackbill R M, Cameron L L, Peddicord J, Fiore M C. Cigarette smoking prevalence by occupation in the United States: a comparison between 1978 to 1980 and 1987 to 1990.  J Occup Med . 1994;  36 516-525
• 64 Haire-Joshu D, Morgan G, Fisher Jr B E. Determinants of cigarette smoking.  Clin Chest Med . 1991;  4 711-725
• 65 Schechter M S. Poverty and Disease Severity in CF: Social and Biological Implications.  Pediatr Pulmonol Suppl . 1999;  119 156-157
• 66 Burns J L, Gibson R L, McNamara S. et al . Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.  J Infect Dis . 2001;  183 444-452
• 67 Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa J Pediatr .  1990;  116 714-719
• 68 Nixon G M, Armstrong D S, Carzino R. et al . Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.  J Pediatr . 2001;  138 699-704
• 69 Hudson V L, Wielinski C L, Regelmann W E. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.  J Pediatr . 1993;  122 854-860
• 70 Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson R L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.  Pediatr Pulmonol . 2002;  34 91-100
• 71 Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.  Pediatr Pulmonol . 1995;  19 10-15
• 72 Jones A M, Dodd M E, Doherty C J, Govan J R, Webb A K. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa Thorax .  2002;  57 924-925
• 73 Henry R L, Mellis C M, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis.  Pediatr Pulmonol . 1992;  12 158-161
• 74 Johnson C, Butler S M, Konstan M W, Morgan W, Wohl M E. Factors influencing outcomes in cystic fibrosis: a center-based analysis.  Chest . 2003;  123 20-27
• 75 Maselli J H, Sontag M K, Norris J M, MacKenzie T, Wagener J S, Accurso F J. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.  Pediatr Pulmonol . 2003;  35 257-262
• 76 Ratjen F, Comes G, Paul K, Posselt H G, Wagner T O, Harms K. Effect of continuous antistaphylococcal therapy on the rate of P aeruginosa acquisition in patients with cystic fibrosis.  Pediatr Pulmonol . 2001;  31 13-16
• 77 Tummler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.  J Clin Microbiol . 1991;  29 1265-1267
• 78 Kosorok M R, Jalaluddin M, Farrell P M. et al . Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.  Pediatr Pulmonol . 1998;  26 81-88
• 79 Farrell P M, Shen G, Splaingard M. et al . Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.  Pediatrics . 1997;  100 E2
• 80 Hoiby N, Pedersen S S. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.  Acta Paediatr Scand . 1989;  78 395-404
• 81 Pedersen S S, Jensen T, Pressler T, Hoiby N, Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?.  Acta Paediatr Scand . 1986;  75 840-845
• 82 Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients.  Pediatr Infect Dis J . 1990;  9 494-498
• 83 Armstrong D, Grimwood K, Carlin J B. et al . Severe viral respiratory infections in infants with cystic fibrosis.  Pediatr Pulmonol . 1998;  26 371-379
• 84 LiPuma J J. Burkholderia cepacia: management issues and new insights.  Clin Chest Med . 1998;  19 473-486
• 85 Ledson M J, Gallagher M J, Jackson M, Hart C A, Walshaw M J. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.  Thorax . 2002;  57 142-145
• 86 McCloskey M, McCaughan J, Redmond A O, Elborn J S. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.  Ir J Med Sci . 2001;  170 28-31
• 87 Muhdi K, Edenborough F P, Gumery L. et al . Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.  Thorax . 1996;  51 374-377
• 88 Lewin L O, Byard P J, Davis P B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.  J Clin Epidemiol . 1990;  43 125-131
• 89 Chen J S, Witzmann K A, Spilker T, Fink R J, LiPuma J J. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.  J Pediatr . 2001;  139 643-649
• 90 Govan J R, Brown P H, Maddison J. et al . Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.  Lancet . 1993;  342 15-19
• 91 Whiteford M L, Wilkinson J D, McColl J H. et al . Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.  Thorax . 1995;  50 1194-1198
• 92 Wang E E, Prober C G, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.  N Engl J Med . 1984;  311 1653-1658
• 93 Smyth A R, Smyth R L, Tong C Y, Hart C A, Heaf D P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.  Arch Dis Child . 1995;  73 117-120
• 94 Hiatt P W, Grace S C, Kozinetz C A. et al . Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis.  Pediatrics . 1999;  103 619-626
• 95 Collinson J, Nicholson K G, Cancio E. et al . Effects of upper respiratory tract infections in patients with cystic fibrosis.  Thorax . 1996;  51 1115-1122
• 96 Gardner G, Frank A L, Taber L H. Effects of social and family factors on viral respiratory infection and illness in the first year of life.  J Epidemiol Community Health . 1984;  38 42-48
• 97 Bor D H, Epstein P R. Pathogenesis of respiratory infection in the disadvantaged.  Semin Respir Infect . 1991;  6 194-203
• 98 Busse W W, Kiecolt-Glaser J K, Coe C, Martin R J, Weiss S T, Parker S R. NHLBI Workshop summary: stress and asthma.  Am J Respir Crit Care Med . 1995;  151 249-252
• 99 Patterson J M, Budd J, Goetz D, Warwick W J. Family correlates of a 10-year pulmonary health trend in cystic fibrosis.  Pediatrics . 1993;  91 383-389
• 100 Wallander J L, Varni J W. Adjustment in children with chronic physical disorders: programmatic research on a disability-stress-coping model. In: LaGreca AM, Siegal L, Wallander JL, Walker CE, eds. Stress and Coping in Child Health New York: Guilford Press 1992: 279-298
• 101 Quittner A L, DiGirolamo A M, Michel M, Eigen H. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase.  J Pediatr Psychol . 1992;  17 683-704
• 102 Wright R J, Steinbach S F. Violence: an unrecognized environmental exposure that may contribute to greater asthma morbidity in high risk inner-city populations.  Environ Health Perspect . 2001;  109 1085-1089
• 103 Wright R J, Rodriguez M, Cohen S. Review of psychosocial stress and asthma: an integrated biopsychosocial approach.  Thorax . 1998;  53 1066-1074
• 104 Quittner A L, DiGirolamo A M. Family adaptation to childhood disability and illness. In: Ammerman RT, Campo JV, eds. Handbook of Pediatric Psychology and Psychiatry Boston: Allyn & Bacon 1998: 70-102
• 105 Patterson J M, McCubbin H I, Warwick W J. The impact of family functioning on health changes in children with cystic fibrosis.  Soc Sci Med . 1990;  31 159-164
• 106 Thompson R J, Gustafson K E, Hamlett K W, Spock A. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment.  J Pediatr Psychol . 1992;  17 741-755
• 107 Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis.  Curr Opin Pulm Med . 1996;  2 457-461
• 108 Schoni M H, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review.  Clin Nutr . 2000;  19 79-85
• 109 Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis.  J Pediatr . 1994;  124 244-249
• 110 Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross-sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.  Thorax . 2002;  57 596-601
• 111 Konstan M W, Butler S M, Johnson C A, Wagener J S, Lai H C, Morgan W J. The relationship between nutritional status in early life and pulmonary function in cystic fibrosis.  Pediatr Pulmonol Suppl . 1999;  19 155-1156
• 112 Walker S A, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings.  J Pediatr Gastroenterol Nutr . 1998;  27 53-56
• 113 James W P, Nelson M, Ralph A, Leather S. Socioeconomic determinants of health: the contribution of nutrition to inequalities in health.  BMJ . 1997;  314 1545-1549
• 114 Kawchak D A, Zhao H, Scanlin T F, Tomezsko J L, Cnaan A, Stallings V A. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis.  J Pediatr . 1996;  129 119-129
• 115 Marcus M S, Sondel S A, Farrell P M. et al . Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.  Am J Clin Nutr . 1991;  54 578-585
• 116 Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis.  J Psychosom Res . 1999;  47 623-634
• 117 Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis.  Soc Sci Med . 2001;  53 1163-1174
• 118 Nixon P A, Orenstein D M, Kelsey S F, Doershuk C F. The prognostic value of exercise testing in patients with cystic fibrosis.  N Engl J Med . 1992;  327 1785-1788
• 119 Orenstein D M, Nixon P A. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function.  Pediatr Pulmonol . 1991;  10 101-105
• 120 Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis.  J Hum Nutr Diet . 2001;  14 83-91
• 121 Abbott J, Conway S, Etherington C. et al . Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers.  J Behav Med . 2000;  23 501-517
• 122 Truby H, Paxton A S. Body image and dieting behavior in cystic fibrosis.  Pediatrics . 2001;  107 E92
• 123 Lai H C, Kosorok M R, Laxova A, Makholm L M, Farrell P M. Delayed diagnosis of US females with cystic fibrosis.  Am J Epidemiol . 2002;  156 165-173
• 124 Braun L. Race, ethnicity, and health: can genetics explain disparities?.  Perspect Biol Med . 2002;  45 159-174
• 125 Hamosh A, FitzSimmons S C, Macek Jr M, Knowles M R, Rosenstein B J, Cutting G R. Comparison of the clinical manifestation of cystic fibrosis in black and white patients.  J Pediatr . 1998;  132 255-259
• 126 Aligne C A, Auinger P, Byrd R S, Weitzman M. Risk factors for pediatric asthma: contributions of poverty, race, and urban residence.  Am J Respir Crit Care Med . 2000;  162 873-877
• 127 Litonjua A A, Carey V J, Weiss S T, Gold D R. Race, socioeconomic factors, and area of residence are associated with asthma prevalence.  Pediatr Pulmonol . 1999;  28 394-401
• 128 Miller J E. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use.  Am J Public Health . 2000;  90 428-430
• 129 Persky V W, Slezak J, Contreras A. et al . Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children.  Ann Allergy Asthma Immunol . 1998;  81 266-271
• 130 Corey M, McLaughlin F J, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.  J Clin Epidemiol . 1988;  41 583-591
• 131 Thomas J, Cook D J, Brooks D. Chest physical therapy management of patients with cystic fibrosis: a meta-analysis.  Am J Respir Crit Care Med . 1995;  151 846-850
• 132 Fuchs H J, Borowitz D S, Christiansen D H. et al . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.  N Engl J Med . 1994;  331 637-642
• 133 McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.  Chest . 1996;  110 889-895
• 134 Quan J M, Tiddens H A, Sy J P. et al . A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.  J Pediatr . 2001;  139 813-820
• 135 Ramsey B W, Pepe M S, Quan J M. et al . Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.  N Engl J Med . 1999;  340 23-30
• 136 Equi A, Balfour-Lynn I M, Bush A, Rosenthal M. Long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.  Lancet . 2002;  360 978-984
• 137 Frederiksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.  Pediatr Pulmonol . 1996;  21 153-158
• 138 Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.  Pediatr Pulmonol . 1997;  23 330-335
• 139 Rosenecker J, Hofler R, Steinkamp G. et al . Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome.  Eur J Med Res . 2001;  6 345-350
• 140 Aris R M, Lester G E, Renner J B. et al . Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation.  Am J Respir Crit Care Med . 2000;  162 941-946
• 141 Colombo C, Battezzati P M, Crosignani A. et al . Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome.  Hepatology . 2002;  36 1374-1382
• 142 Subcommittee TCFFCCaG. Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers.  Am J Dis Child . 1990;  144 1311-1312
• 143 Collins C E, MacDonald-Wicks L, Rowe S, O'Loughlin E V, Henry R L. Normal growth in cystic fibrosis associated with a specialised centre.  Arch Dis Child . 1999;  81 241-246
• 144 Mahadeva R, Webb K, Westerbeek R C. et al . Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross-sectional study.  BMJ . 1998;  316 1771-1775
• 145 Adler N E, Boyce W T, Chesney M A, Folkman S, Syme S I. Socioeconomic inequalities in health.  JAMA . 1993;  269 3140-3145
• 146 Curtis J R, Burke W, Kassner A, Aitkin M L. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.  Am J Respir Crit Care Med . 1997;  155 1921-1924
• 147 Hahn B, Flood A B. No insurance, public insurance, and private insurance: do these options contribute to differences in general health?.  J Health Care Poor Underserved . 1995;  6 41-59
• 148 Henley L D, Hill I D. Errors, gaps, and misconceptions in the disease-related knowledge of cystic fibrosis patients and their families.  Pediatrics . 1990;  85 1008-1014
• 149 Henley L D, Hill I D. Global and specific disease-related information needs of cystic fibrosis patients and their families.  Pediatrics . 1990;  85 1015-1021
• 150 Konstan M W, Butler S M, Schidlow D V, Morgan W J, Julius J R, Johnson C A. Patterns of medical practice in cystic fibrosis, II: Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.  Pediatr Pulmonol . 1999;  28 248-254
• 151 Konstan M W, Butler S M, Schidlow D V, Morgan W J, Julius J R, Johnson C A. Patterns of medical practice in cystic fibrosis, I: Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.  Pediatr Pulmonol . 1999;  28 242-247
• 152 Abbott J, Dodd M, Webb A K. Health perceptions and treatment adherence in adults with cystic fibrosis.  Thorax . 1996;  51 1233-1238
• 153 Conway S P, Pond M N, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis.  Thorax . 1996;  51 29-33
• 154 Quittner A L, Espelage D L, Ievers-Landis C, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information.  J Clin Psychol Med Settings . 2000;  7 41-54
• 155 Greenberg R N. Overview of patient compliance with medication dosing: a literature review.  Clin Ther . 1984;  6 592-599
• 156 Lask B. Nonadherence to treatment in cystic fibrosis.  J R Soc Med . 1994;  87 25-27
• 157 Koocher G P, McGrath M L, Gudas L J. Typologies of nonadherence in cystic fibrosis.  J Dev Behav Pediatr . 1990;  11 353-358
• 158 Gudas L J, Koocher G P, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis.  J Dev Behav Pediatr . 1991;  12 236-242
• 159 DiMatteo M R. Enhancing patient adherence to medical recommendations.  JAMA . 1994;  271 79-82
• 160 Eddy M E, Carter B D, Kronenberger W G. et al . Parent relationships and compliance in cystic fibrosis.  J Pediatr Health Care . 1998;  12 196-202
• 161 Ievers C E, Brown R T, Drotar D, Caplan D, Pishevar B S, Lambert R G. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers.  J Dev Behav Pediatr . 1999;  20 335-343
• 162 Quittner A L, Drotar D, Ievers-Landis C, Seidner D, Slocum N, Jacobsen J. Adherence to medical teatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions. In: Drotar D, ed. Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods, and Interventions Mahwah, NJ: Erlbaum Associates; 2000: 383-407
• 163 Clinical Practice Guidelines for Cystic Fibrosis Committee. Clinical Practice Guidelines for Cystic Fibrosis.  Bethesda: Cystic Fibrosis Foundation; 1997
• 164 Schechter M S. Demographic and Center-Related Characteristics Associated with Low Weight in Pediatric CF Patients.  Pediatric Pulmonology . 2002;  suppl 22 156-157
• 165 Berwick D M. Continuous improvement as an ideal in health care.  N Engl J Med . 1989;  320 53-56
• 166 Institute of Medicine Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century.  Washington, DC: National Academy Press 2001